CS logo
small CS logo
Tennessee Oncology, PLLC

Nashville, Tennessee, United States
Medical clinic in Nashville, Tennessee
3443 Dickerson Pike #760, Nashville, TN 37207

About Tennessee Oncology, PLLC


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
SCRI Development Innovations, LLC
105
Pfizer
42
Eli Lilly and Company
35
Hoffmann-La Roche
27
Bristol-Myers Squibb
23
Gilead Sciences
13
Genentech, Inc.
11
Boehringer Ingelheim
7
Novartis Pharmaceuticals
5
Amgen
4
BeiGene
4
Total Rows: 73

Clinical Trials at Tennessee Oncology, PLLC


During the past decade, Tennessee Oncology, PLLC conducted 181 clinical trials. In the 10-year time frame, 181 clinical trials started and 142 clinical trials were completed, i.e. on average, 78.5% percent of trials that started reached the finish line to date. In the past 5 years, 67 clinical trials started and 53 clinical trials were completed. i.e. 79.1% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years29292828212117171919171729292020111313131325251414242414142020131366Started TrialsCompleted Trails201520162017201820192020202120222023010203040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
2003-06-01
2006-12-01
Completed
440
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2005-05-01
Completed
520

Rows per page:

1–100 of 363

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Tennessee Oncology, PLLC" #1 sponsor was "SCRI Development Innovations, LLC" with 105 trials, followed by "Pfizer" with 42 trials sponsored, "Eli Lilly and Company" with 35 trials sponsored, "Hoffmann-La Roche" with 27 trials sponsored and "Bristol-Myers Squibb" with 27 trials sponsored. Other sponsors include 126 different institutions and companies that sponsored additional 73 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tennessee Oncology, PLLC" #1 collaborator was "Genentech, Inc." with 27 trials as a collaborator, "Novartis" with 22 trials as a collaborator, "Bristol-Myers Squibb" with 11 trials as a collaborator, "GlaxoSmithKline" with 11 trials as a collaborator and "Bayer" with 9 trials as a collaborator. Other collaborators include 116 different institutions and companies that were collaborators in the rest 60 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Tennessee Oncology, PLLC


According to Clinical.Site data, the most researched conditions in "Tennessee Oncology, PLLC" are "Breast Cancer" (33 trials), "Multiple Myeloma" (17 trials), "Non-Small Cell Lung Cancer" (16 trials), "Metastatic Breast Cancer" (15 trials) and "Ovarian Cancer" (14 trials). Many other conditions were trialed in "Tennessee Oncology, PLLC" in a lesser frequency.

Clinical Trials Intervention Types at Tennessee Oncology, PLLC


Most popular intervention types in "Tennessee Oncology, PLLC" are "Drug" (344 trials), "Biological" (38 trials), "Other" (11 trials), "Procedure" (6 trials) and "Radiation" (4 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (35 trials), "Placebo" (34 trials), "Paclitaxel" (27 trials), "Gemcitabine" (26 trials) and "Bevacizumab" (23 trials). Other intervention names were less common.

Clinical Trials Genders at Tennessee Oncology, PLLC


The vast majority of trials in "Tennessee Oncology, PLLC" are 315 trials for "All" genders, 34 trials for "Female" genders and 14 trials for "Male" genders.

Clinical Trials Status at Tennessee Oncology, PLLC


Currently, there are NaN active trials in "Tennessee Oncology, PLLC". undefined are not yet recruiting, 57 are recruiting, 56 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 191 completed trials in Tennessee Oncology, PLLC, 2 suspended trials, and 48 terminated clinical trials to date.
Out of the total trials that were conducted in Tennessee Oncology, PLLC, 113 "Phase 1" clinical trials were conducted, 193 "Phase 2" clinical trials and 85 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status